Hemostatic Abnormalities and Arterial Thrombosis

Semin Thromb Hemost 2009; 35(5): 449-450
DOI: 10.1055/s-0029-1234148

PREFACE

Pieter W. Kamphuisen¹ , Frits R. Rosendaal² , Harry R. Büller¹

¹Department of Vascular Medicine, Academic Medical Center Amsterdam, The Netherlands
²Departments of Clinical Epidemiology and Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

1 Prandoni P, Bilora F, Marchiori A et al.. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003; 348 1435-1441
2 Becattini C, Agnelli G, Prandoni P et al.. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J. 2005; 26 77-83
3 Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen P W. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008; 117 93-102
4 Ray J G, Mamdani M, Tsuyuki R T, Anderson D R, Yeo E L, Laupacis A. Use of statins and subsequent development of deep vein thrombosis. Arch Intern Med. 2001; 161 1410
5 Ramcharan A S, van Stralen K J, Mantel-Teeuwisse A K, Rosendaal F R, Doggen C JM. HMG-CoA reductase inhibitors are associated with a reduced risk of venous thrombosis. J Thromb Haemost. 2009; 7 514-520
6 Sørensen H T, Horvath-Puho E, Søgaard K K et al.. Arterial cardiovascular events, statins, low dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost. 2009; 7 521-528
7 Glynn R J, Danielson E, Fonseca F AH et al.. A randomised trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009; 360 1851-1861